Pacific 8 Ventures is a venture capital firm that invests at the nexus of cutting-edge technology platforms and biology/medicine. We focus on early-stage startups. Our investments consist of high-performing companies in the area of synthetic biology, gene therapy, CRISPR, machine learning/artificial intelligence, digital therapeutics, and more. Founders appreciate that we can be more than just a capital partner but also a strategic partner for market access given our LP and advisor base consists of groups that own and operate hospitals, clinics, health insurance, and life insurance companies.